𝔖 Bobbio Scriptorium
✦   LIBER   ✦

NPHS2mutation associated with recurrence of proteinuria after transplantation

✍ Scribed by Heiko Billing; Dominik Müller; Rainer Ruf; Anne Lichtenberger; Friedhelm Hildebrandt; Christian August; Uwe Querfeld; Dieter Haffner

Publisher
Springer
Year
2004
Tongue
English
Weight
210 KB
Volume
19
Category
Article
ISSN
0931-041X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of enalapril on proteinuria after
Effect of enalapril on proteinuria after kidney transplantation
✍ Krzysztof Rell; Jacek Linde; Maria Morzycka-Michalik; Zbigniew Gaciong; Mieczysł 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 453 KB

We studied the effect of enalapril, an inhibitor of angiotensin-converting enzyme (iACE), on proteinuria and renal function in recipients of renal allografts. Twenty-two patients with post-transplant nephrotic syndrome were treated with incremental doses of enalapril for 1 year. Urinary protein excr

Recurrence of hepatitis B is associated
Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation
✍ Nam-Joon Yi; Kyung-Suk Suh; Jai Young Cho; Choon Hyuck Kwon; Kwang-Woong Lee; Ja 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

The incidence of hepatitis B (HB) recurrence after a liver transplantation has been reduced by prophylaxis with hepatitis B immunoglobulin (HBIG) and lamivudine. However, the long-term incidence of recurrence is Ͻ10%, and the factors associated with HB recurrence are unclear. This study analyzed the

Factors associated with viral breakthrou
Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation
✍ Henry Lik-Yuen Chan; Albert Ka-Keung Chui; Wan-Yee Lau; Francis Ka-Leung Chan; M 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

This study aimed to investigate the factors associated with viral breakthrough among liver transplant recipients who receive lamivudine monoprophylaxis. Consecutive patients receiving liver transplantation for HBV-related liver disease from June 1999 to October 2000 were studied. All patients receiv